tiprankstipranks
Trending News
More News >
ADMA Biologics (ADMA)
NASDAQ:ADMA
US Market

ADMA Biologics (ADMA) Revenue

Compare
2,975 Followers

ADMA Biologics Revenue

ADMA Biologics had a revenue of 134.22M in the quarter ending Sep 30, 2025, with 10.03%. This bring the company's revenue in the last twelve months to 488.56M, Decreased 3.03%. In the fiscal year ending Dec 31, 2024, ADMA Biologics had annual revenue of 426.45M with 65.15% growth.
Revenue (ttm)
488.56M
Revenue Growth
27.62%
P/S Ratio
10.93
Revenue/Employee
$622,561
Employees
685
Market Cap
$4.66B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
426.45M168.24M+165.15%
Dec 31, 2023
258.21M104.14M+167.59%
Dec 31, 2022
154.08M73.14M+190.36%
Dec 31, 2021
80.94M38.72M+191.72%
Dec 31, 2020
42.22M12.87M+143.85%
Dec 31, 2019
29.35M12.36M+172.79%
Dec 31, 2018
16.99M-5.78M+74.63%
Dec 31, 2017
22.76M12.10M+213.49%
Dec 31, 2016
10.66M